Patent details
301155
Product Name:
abrocitinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301155
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2958921
Status:
SPC granted but not yet in force
Application number:
301155
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/21/1593
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/12/2021
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
22/12/2021
First Marketing Authorization date:
09/12/2021
Grant date:
23/02/2022
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
22/12/2021
SPC/SPC Extension Expiration Date:
08/12/2036
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
16/06/2023
Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, 10001-2192, New York, NY, United States of America (US)
Historical Applicant/holder
From:
22/12/2021
To:
16/06/2023
Name:
Pfizer Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)
Agent
Name:
dr. R.C. van Duijvenbode c.s.
From:
20/04/2022
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
09/22
Publication date:
02/03/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
51/21
Publication date:
22/12/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of Address
Change Kind/ Decision Type:
Owner
Deed Number:
RC202301234A
Date Registered:
16/06/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
28/02/2034
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
20/04/2022
SPC Documents
Certificate SPC
1
PDF
/7/7/4/5/5/0800755477/docs/301155_6_supplprotectioncertificate20220420041156350.pdf
20/04/2022
Outgoing Correspondence
Letter to applicant
1
PDF
/7/7/4/5/5/0800755477/docs/301155_7_475235l173.pdf
23/02/2022
Outgoing Correspondence
Decision grant
1
PDF
/7/7/4/5/5/0800755477/docs/301155_3_463929l504a.pdf
22/12/2021
Outgoing Correspondence
Confirmation receipt request
1
PDF
/7/7/4/5/5/0800755477/docs/301155_0_452318l174.pdf
22/12/2021
SPC Documents
Summary of the characteristics of the product
24
PDF
/7/7/4/5/5/0800755477/docs/301155_1_supplprotectioncertificate20211222015752083.pdf
22/12/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/7/7/4/5/5/0800755477/docs/301155_2_supplprotectioncertificate20211222015516604.pdf
22/12/2021
SPC Documents
Annex SPC
25
PDF
/7/7/4/5/5/0800755477/docs/301155_4_supplprotectioncertificate20211222015838213.pdf
22/12/2021
Application Form
First filed application form
2
PDF
/7/7/4/5/5/0800755477/docs/301155_5_applicationform20211222013623545.pdf